NCT01592318View on ClinicalTrials.gov

A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Healthy Volunteer

Interventions

DRUG

danoprevir

Fixed dose combination tablet with ritonavir, single oral dose

DRUG

danoprevir

Reference tablet, single oral dose

DRUG

ritonavir

Fixed dose combination tablet with danoprevir, single oral dose

DRUG

ritonavir

Reference tablet, single oral dose

Trial Locations (1)

8011

Christchurch

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01592318 - A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy Volunteers | Biotech Hunter | Biotech Hunter